Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Mabs|June 12, 2012
7th cancer scientific forum of theCancéropôle Lyon Auvergne Rhône-Alpes: March 20-21, 2012, Lyon, FrancePetrus J Pauwels, Charles Dumontet, Janice M Reichert, et al.
Immunity|October 2, 2002
Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentationYves Delneste, Giovanni Magistrelli, Jean Gauchat, et al.
Investigational New Drugs|September 25, 2009
Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport systemAnna Kruczynski, Isabelle Vandenberghe, Arnaud Pillon, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 19, 2005
Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cellsAlain Beck, Marie-Claire Bussat, Nathalie Zorn, et al.
Current Pharmaceutical Biotechnology|December 17, 2008
Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteinsAlain Beck, Elsa Wagner-Rousset, Marie-Claire Bussat, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor ImmunityElie Dheilly, Stefano Majocchi, Valéry Moine, et al.
Molecular Cancer Therapeutics|October 10, 2019
Efficacy of the Antibody-Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid TumorsBarbara Akla, Matthieu Broussas, Noureddine Loukili, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|July 3, 2007
Peptides as tools and drugs for immunotherapiesAlain Beck, Christine Klinguer-Hamour, Marie-Claire Bussat, et al.
Virology|December 17, 2002
Passive transfer of serum antibodies induced by BBG2Na, a subunit vaccine, in the elderly protects SCID mouse lungs against respiratory syncytial virus challengeHélène Plotnicky-Gilquin, Dominique Cyblat-Chanal, Liliane Goetsch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2017
Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific AntibodiesElie Dheilly, Valéry Moine, Lucile Broyer, et al.
Pageof 4